Aeovian Pharmaceuticals Private
Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Estimated Revenue:
$1M to $10M
Technology:
NeuroTech
Industry:
PharmTech
Investor Type:
Early Stage Venture
Last Funding Type:
Series A
Total Funding:
37000000
Funding Status:
Early Stage Venture
Headquarters:
San Francisco, California, United States
Investors Number:
4
Number Of Exists:
Series A
Last Funding Date:
2019
Founded Date:
2012
Employee Number:
1-10